Serious & Notifiable Infections — MCQs

A 25-year-old man presents to the emergency department with a 14-hour history of severe headache, fever, and photophobia. He is drowsy with a Glasgow Coma Scale of 13/15. Purpuric lesions are visible on his legs. Blood tests show: WBC 19.5 × 10⁹/L, neutrophils 16.8 × 10⁹/L, CRP 245 mg/L, prothrombin time 18 seconds, APTT 42 seconds, fibrinogen 1.2 g/L, platelets 78 × 10⁹/L. He is started on immediate management. His younger sister (aged 18) who lives with him attends the hospital worried about her risk. Which one of the following is the most appropriate chemoprophylaxis for the sister?

Q23

Which one of the following clinical scenarios requires contact tracing and chemoprophylaxis for tuberculosis according to current UK guidelines?

Q24

A 34-year-old woman presents with a 6-week history of headache and personality change. Her husband reports she has become increasingly forgetful and confused. She has no significant past medical history and takes no regular medications. On examination, she is afebrile, has mild photophobia, and demonstrates cognitive impairment with difficulty with short-term memory. Lumbar puncture shows: opening pressure 26 cmH₂O, CSF protein 1.8 g/L, glucose 1.6 mmol/L (plasma glucose 5.4 mmol/L), white cells 180/mm³ (95% lymphocytes). MRI brain shows meningeal enhancement predominantly at the base of the skull. What is the single most important investigation to guide immediate management?

Q25

A 56-year-old man with end-stage renal failure on peritoneal dialysis is diagnosed with pulmonary tuberculosis. Sputum culture confirms Mycobacterium tuberculosis fully sensitive to first-line agents. His current medications include alfacalcidol, calcium carbonate, and erythropoietin. Which one of the following represents the most appropriate dosing regimen for his anti-tuberculosis therapy?

Q26

A 3-year-old girl presents with a 6-hour history of fever, irritability, and reduced consciousness. Examination reveals temperature 39.4°C, Glasgow Coma Scale 11/15, and a non-blanching purpuric rash on her trunk and limbs. Her capillary refill time is 4 seconds. Blood pressure is 75/40 mmHg and heart rate 165 bpm. She received three doses of the meningococcal B vaccine and the ACWY vaccine as per the UK immunisation schedule. Which one of the following is the most likely causative organism?

Q27

A 29-year-old woman with no significant past medical history presents with a 12-hour history of severe headache, photophobia, and vomiting. She is febrile at 38.9°C with marked neck stiffness. Blood tests show: WBC 18.2 × 10⁹/L, CRP 156 mg/L, platelets 145 × 10⁹/L. CT head is normal. Lumbar puncture is performed: opening pressure 32 cmH₂O, CSF appears turbid. While awaiting CSF analysis results, she is started on appropriate empirical antibiotic therapy. Which one of the following factors would most strongly indicate a need to extend her antibiotic treatment duration beyond the standard course?

Q28

A 4-year-old boy who recently emigrated from Pakistan presents with a 4-week history of lethargy, low-grade fever, and behavioural changes. His mother reports he has been increasingly drowsy over the past week. Examination reveals temperature 37.8°C, Glasgow Coma Scale 13/15, and subtle right-sided weakness. Lumbar puncture shows: opening pressure 24 cmH₂O, CSF protein 3.2 g/L, glucose 1.4 mmol/L (plasma glucose 5.6 mmol/L), white cells 280/mm³ (85% lymphocytes). CT head shows basal meningeal enhancement and hydrocephalus. Which one of the following is the most appropriate initial management?

Q29

A 47-year-old man from Georgia is diagnosed with pulmonary tuberculosis. Molecular testing shows rifampicin resistance. He is started on an appropriate modified regimen. After 4 months of treatment, he reports orange discoloration of his contact lenses. Which one of the following medications in his current regimen is most likely responsible for this adverse effect?

Q30

According to current UK public health guidelines, which one of the following scenarios requires notification of suspected meningococcal disease to the local Health Protection Team before laboratory confirmation?

Serious & Notifiable Infections UK Medical PG Practice Questions and MCQs

Question 21: What is the primary pathophysiological mechanism by which Mycobacterium tuberculosis causes caseous necrosis in infected tissues?

A. Direct cytotoxic effect of mycobacterial cord factor on host cell membranes
B. Hypersensitivity reaction mediated by CD4+ T lymphocytes and macrophage activation (Correct Answer)
C. Ischaemic necrosis secondary to mycobacterial-induced vasculitis and thrombosis
D. Secretion of bacterial exotoxins that directly destroy host tissue architecture
E. Complement-mediated cytolysis of infected cells through antibody-dependent mechanisms

Explanation: ***Hypersensitivity reaction mediated by CD4+ T lymphocytes and macrophage activation*** - Caseous necrosis is the result of a **Type IV delayed-type hypersensitivity** reaction where **CD4+ Th1 cells** activate macrophages via **Interferon-gamma**. - This intense immune-mediated response leads to the formation of **granulomas** and the characteristic cheese-like tissue destruction intended to contain the pathogen. *Direct cytotoxic effect of mycobacterial cord factor on host cell membranes* - **Cord factor** (trehalose dimycolate) is a virulence factor responsible for the **serpentine growth** of M. tuberculosis and inhibits leukocyte migration. - While it contributes to pathogenicity and granuloma maintenance, it does not possess a **direct cytotoxic** mechanism that causes the necrosis itself. *Ischaemic necrosis secondary to mycobacterial-induced vasculitis and thrombosis* - Though **vasculitis** can occur as a complication (especially in **CNS tuberculosis**), it is not the standard mechanism for caseous necrosis. - Caseation is defined by **immune-mediated** cell death rather than a primary lack of blood supply or **microvascular thrombosis**. *Secretion of bacterial exotoxins that directly destroy host tissue architecture* - Unlike organisms like Clostridium, *Mycobacterium tuberculosis* does not secrete significant **lethal exotoxins**. - Pathogenicity is primarily due to its ability to survive within **alveolar macrophages** and provoke a host immune response. *Complement-mediated cytolysis of infected cells through antibody-dependent mechanisms* - Tuberculosis defense relies almost entirely on **cell-mediated immunity** rather than humoral (antibody) pathways. - **Complement-mediated lysis** is not a feature of TB pathogenesis, as the bacteria are specialized **intracellular pathogens** that evade such extracellular defenses.

Question 22: A 25-year-old man presents to the emergency department with a 14-hour history of severe headache, fever, and photophobia. He is drowsy with a Glasgow Coma Scale of 13/15. Purpuric lesions are visible on his legs. Blood tests show: WBC 19.5 × 10⁹/L, neutrophils 16.8 × 10⁹/L, CRP 245 mg/L, prothrombin time 18 seconds, APTT 42 seconds, fibrinogen 1.2 g/L, platelets 78 × 10⁹/L. He is started on immediate management. His younger sister (aged 18) who lives with him attends the hospital worried about her risk. Which one of the following is the most appropriate chemoprophylaxis for the sister?

A. Ciprofloxacin 500 mg single oral dose (Correct Answer)
B. Rifampicin 600 mg twice daily for 2 days
C. Ceftriaxone 250 mg intramuscular single dose
D. Benzylpenicillin 1.2 g intramuscular single dose
E. Azithromycin 500 mg once daily for 5 days

Explanation: ***Ciprofloxacin 500 mg single oral dose*** - This is the **first-line** recommended **chemoprophylaxis** for close contacts of individuals with invasive **meningococcal disease** in adults and older children. - Its **single oral dose** makes it convenient, ensuring good compliance, and it effectively eradicates **nasopharyngeal carriage** of *Neisseria meningitidis*. *Rifampicin 600 mg twice daily for 2 days* - While effective for **meningococcal chemoprophylaxis**, it requires **multiple doses** over two days (four doses total), which is less convenient than single-dose options. - It can cause **orange discoloration** of body fluids and has significant **drug interactions** due to its potent CYP450 enzyme induction. *Ceftriaxone 250 mg intramuscular single dose* - This is an effective option for **meningococcal prophylaxis**, particularly recommended for **pregnant women** or those who cannot tolerate oral medications. - However, for a healthy, orally compliant 18-year-old, an **intramuscular injection** is generally less preferred than a single oral dose. *Benzylpenicillin 1.2 g intramuscular single dose* - **Benzylpenicillin** is used for the **treatment** of suspected **meningococcal disease** (especially in pre-hospital settings) due to its bactericidal activity. - It is **not effective** as chemoprophylaxis because it does not reliably eliminate **nasopharyngeal carriage** of *Neisseria meningitidis*, which is the goal of prophylaxis. *Azithromycin 500 mg once daily for 5 days* - **Azithromycin** is generally **not recommended** as a first-line agent for **meningococcal chemoprophylaxis** according to most national guidelines. - Its role is primarily in prophylaxis for other respiratory infections, such as **pertussis**, or for treating atypical bacterial infections.

Question 23: Which one of the following clinical scenarios requires contact tracing and chemoprophylaxis for tuberculosis according to current UK guidelines?

A. A 45-year-old man with smear-negative, culture-positive pulmonary TB who has been on treatment for 3 weeks
B. A 38-year-old woman with tuberculous lymphadenitis without pulmonary involvement
C. A 52-year-old man with laryngeal tuberculosis who has completed 2 weeks of appropriate therapy (Correct Answer)
D. A 61-year-old woman with pleural tuberculosis and negative sputum samples
E. A 29-year-old man with spinal tuberculosis without respiratory symptoms

Explanation: ***A 52-year-old man with laryngeal tuberculosis who has completed 2 weeks of appropriate therapy*** - **Laryngeal tuberculosis** is highly infectious due to aerosolization of bacilli during coughing and speaking, necessitating stringent public health measures. - Current **UK guidelines** mandate contact tracing and potential chemoprophylaxis for close contacts of patients with laryngeal TB, regardless of the duration of treatment, due to the high risk of transmission. *A 45-year-old man with smear-negative, culture-positive pulmonary TB who has been on treatment for 3 weeks* - While **culture-positive**, the patient being **smear-negative** significantly reduces the immediate risk of transmission compared to smear-positive cases. - After **three weeks of effective treatment**, individuals with pulmonary TB are generally considered non-infectious, reducing the urgency for new contact tracing or chemoprophylaxis unless clinical circumstances suggest otherwise. *A 38-year-old woman with tuberculous lymphadenitis without pulmonary involvement* - **Tuberculous lymphadenitis** is an extrapulmonary form of TB that does not involve the respiratory tract, making it non-contagious. - There is no risk of airborne transmission, so **contact tracing** and **chemoprophylaxis** are not indicated for isolated nodal disease. *A 61-year-old woman with pleural tuberculosis and negative sputum samples* - **Pleural tuberculosis** is a non-infectious form of extrapulmonary TB as the bacteria are confined to the pleural space. - The absence of **positive sputum samples** confirms no respiratory shedding of bacilli, thus precluding the need for contact tracing. *A 29-year-old man with spinal tuberculosis without respiratory symptoms* - **Spinal tuberculosis** (Pott's disease) is a form of extrapulmonary TB that does not involve the lungs or airways. - Without any **respiratory symptoms** or evidence of pulmonary involvement, there is no risk of airborne transmission to contacts.

Question 24: A 34-year-old woman presents with a 6-week history of headache and personality change. Her husband reports she has become increasingly forgetful and confused. She has no significant past medical history and takes no regular medications. On examination, she is afebrile, has mild photophobia, and demonstrates cognitive impairment with difficulty with short-term memory. Lumbar puncture shows: opening pressure 26 cmH₂O, CSF protein 1.8 g/L, glucose 1.6 mmol/L (plasma glucose 5.4 mmol/L), white cells 180/mm³ (95% lymphocytes). MRI brain shows meningeal enhancement predominantly at the base of the skull. What is the single most important investigation to guide immediate management?

A. CSF Ziehl-Neelsen stain and TB culture
B. HIV antibody and p24 antigen testing (Correct Answer)
C. CSF cryptococcal antigen lateral flow assay
D. CSF viral PCR including herpes simplex and varicella zoster
E. Serum and CSF angiotensin-converting enzyme levels

Explanation: ***HIV antibody and p24 antigen testing*** - The profound CSF abnormalities (elevated pressure and protein, very low glucose, lymphocytic pleocytosis) and **basal meningeal enhancement** strongly suggest **subacute meningitis**, likely due to **tuberculosis** or **fungal infection**. - Knowing the patient's **HIV status** is paramount as it fundamentally alters the likelihood of opportunistic infections (e.g., **cryptococcal meningitis** is much more common in HIV) and dictates immediate empirical treatment strategies. *CSF Ziehl-Neelsen stain and TB culture* - While **tuberculous meningitis** is a high suspicion, the **Ziehl-Neelsen stain** has very low sensitivity in CSF, often failing to detect acid-fast bacilli. - **TB culture** is definitive but takes weeks for results, making it unsuitable for guiding **immediate management** in this critically ill patient. *CSF cryptococcal antigen lateral flow assay* - This is a rapid and highly sensitive test for **Cryptococcus**, a potential cause of meningitis, especially in immunocompromised patients. - However, determining the patient's **immunosuppression status** (e.g., HIV) is a more fundamental and immediate step to assess overall risk and guide the interpretation and urgency of further investigations and treatment. *CSF viral PCR including herpes simplex and varicella zoster* - **Viral meningitis/encephalitis** typically presents acutely, not over 6 weeks, and usually does not cause the profound **hypoglycorrhachia** (low CSF glucose) observed in this patient. - **Basal meningeal enhancement** and severe cognitive impairment are not typical features of **HSV** or **VZV** encephalitis, which often present with more focal neurological signs. *Serum and CSF angiotensin-converting enzyme levels* - These tests are used to investigate **neurosarcoidosis**, which can cause chronic meningitis and basal enhancement, but it is a diagnosis of exclusion and less common than infectious causes. - **ACE levels** have poor sensitivity and specificity for **neurosarcoidosis** and would not be the most important immediate investigation given the highly suggestive infectious picture.

Question 25: A 56-year-old man with end-stage renal failure on peritoneal dialysis is diagnosed with pulmonary tuberculosis. Sputum culture confirms Mycobacterium tuberculosis fully sensitive to first-line agents. His current medications include alfacalcidol, calcium carbonate, and erythropoietin. Which one of the following represents the most appropriate dosing regimen for his anti-tuberculosis therapy?

A. Standard daily doses of rifampicin, isoniazid, pyrazinamide, and ethambutol with no adjustment required
B. Standard doses of rifampicin and isoniazid daily, with pyrazinamide and ethambutol given three times weekly
C. Reduce all four first-line drugs to half the standard dose given daily due to reduced clearance
D. Standard daily doses of rifampicin, isoniazid, and pyrazinamide, avoid ethambutol due to risk of optic neuropathy
E. Standard doses of rifampicin and isoniazid daily, pyrazinamide 25-35 mg/kg three times weekly, and avoid ethambutol (Correct Answer)

Explanation: ***Standard doses of rifampicin and isoniazid daily, pyrazinamide 25-35 mg/kg three times weekly, and avoid ethambutol*** - **Rifampicin** and **isoniazid** are predominantly metabolized by the **liver**, allowing for standard daily dosing in patients with **end-stage renal failure** without significant accumulation. - **Pyrazinamide** metabolites are renally cleared, requiring a reduced frequency (e.g., **three times weekly**) to prevent toxicity, while **ethambutol** is generally avoided due to the high risk of **irreversible optic neuropathy** in renal impairment. *Standard daily doses of rifampicin, isoniazid, pyrazinamide, and ethambutol with no adjustment required* - This regimen is inappropriate as **pyrazinamide** and **ethambutol** are substantially cleared by the kidneys, leading to toxic accumulation and severe adverse effects in **ESRF**. - Ignoring dose adjustments for renally excreted drugs in dialysis patients significantly increases the risk of side effects such as **hyperuricemia** (from pyrazinamide) and **vision loss** (from ethambutol). *Standard doses of rifampicin and isoniazid daily, with pyrazinamide and ethambutol given three times weekly* - While **pyrazinamide** often requires reduced frequency (three times weekly) in renal failure, **ethambutol** is typically **avoided** entirely in this population due to its narrow therapeutic index and the high risk of **optic toxicity**. - Using **ethambutol** in ESRD necessitates rigorous monitoring for **visual changes**, which is often impractical and carries a significant risk compared to its benefits. *Reduce all four first-line drugs to half the standard dose given daily due to reduced clearance* - Reducing the daily dose of **rifampicin** and **isoniazid** is incorrect as their metabolism is primarily **hepatic**, potentially leading to **subtherapeutic levels** and **treatment failure**. - For renally cleared drugs like pyrazinamide, adjusting the **frequency** rather than simply reducing the daily dose is generally preferred to maintain adequate drug exposure while preventing accumulation. *Standard daily doses of rifampicin, isoniazid, and pyrazinamide, avoid ethambutol due to risk of optic neuropathy* - Although avoiding **ethambutol** is correct in ESRD, this option incorrectly suggests giving **pyrazinamide daily**. - **Pyrazinamide** requires **frequency adjustment** in renal failure to prevent accumulation of its renally excreted metabolites, which can cause severe **hepatotoxicity** and **gout**.

Question 26: A 3-year-old girl presents with a 6-hour history of fever, irritability, and reduced consciousness. Examination reveals temperature 39.4°C, Glasgow Coma Scale 11/15, and a non-blanching purpuric rash on her trunk and limbs. Her capillary refill time is 4 seconds. Blood pressure is 75/40 mmHg and heart rate 165 bpm. She received three doses of the meningococcal B vaccine and the ACWY vaccine as per the UK immunisation schedule. Which one of the following is the most likely causative organism?

A. Neisseria meningitidis serogroup B (Correct Answer)
B. Neisseria meningitidis serogroup W
C. Streptococcus pneumoniae
D. Haemophilus influenzae type b
E. Neisseria meningitidis serogroup Y

Explanation: ***Neisseria meningitidis serogroup B*** - **Meningococcal B** remains the most common cause of invasive meningococcal disease in the UK, even in vaccinated children, due to **vaccine failure** or strains not covered by the **Bexsero** vaccine. - The classic triad of **fever**, **non-blanching purpuric rash**, and rapid progression to **septic shock** (hypotension and prolonged capillary refill) is pathognomonic for meningococcal septicaemia. *Neisseria meningitidis serogroup W* - While serogroup W has increased in incidence, the **MenACWY vaccine** administered in the UK schedule provides robust protection, making it less likely than serogroup B. - It often presents with atypical symptoms like **gastrointestinal distress** or severe **epiglottitis**, though it can cause standard septicaemia. *Streptococcus pneumoniae* - **Streptococcus pneumoniae** is a common cause of meningitis and sepsis but is less frequently associated with a rapidly spreading **purpuric rash**. - Most children are protected by the **pneumococcal conjugate vaccine (PCV)** included in the routine immunisation schedule. *Haemophilus influenzae type b* - **Hib** infections have become extremely rare in the UK since the introduction of the **Hib vaccine**, which is highly effective. - Clinical presentation usually involves **meningitis**, **epiglottitis**, or **pneumonia** rather than the specific purpuric rash seen in meningococcal disease. *Neisseria meningitidis serogroup Y* - Serogroup Y is covered by the **MenACWY vaccine** given to adolescents, but even indirect protection and routine schedules make it a less common cause than serogroup B in young children. - It typically accounts for a smaller percentage of invasive disease cases compared to the **meningococcal B** strain.

Question 27: A 29-year-old woman with no significant past medical history presents with a 12-hour history of severe headache, photophobia, and vomiting. She is febrile at 38.9°C with marked neck stiffness. Blood tests show: WBC 18.2 × 10⁹/L, CRP 156 mg/L, platelets 145 × 10⁹/L. CT head is normal. Lumbar puncture is performed: opening pressure 32 cmH₂O, CSF appears turbid. While awaiting CSF analysis results, she is started on appropriate empirical antibiotic therapy. Which one of the following factors would most strongly indicate a need to extend her antibiotic treatment duration beyond the standard course?

A. CSF opening pressure of 32 cmH₂O at initial lumbar puncture
B. Persistence of fever for 5 days after starting appropriate antibiotic therapy (Correct Answer)
C. CSF white cell count of 5,000 cells/mm³ at initial presentation
D. Development of seizure activity on day 2 of admission
E. Isolation of penicillin-resistant Streptococcus pneumoniae from CSF culture

Explanation: ***Persistence of fever for 5 days after starting appropriate antibiotic therapy*** - **Persistent fever** beyond 5-7 days after initiating appropriate antibiotic therapy for bacterial meningitis is a significant indicator of treatment failure or the development of complications such as **brain abscess**, **subdural empyema**, or **ventriculitis**. - This clinical sign necessitates further evaluation (e.g., repeat imaging or lumbar puncture) and almost always warrants an **extension of antibiotic duration** to ensure complete eradication of the infection and resolution of complications. *CSF opening pressure of 32 cmH₂O at initial lumbar puncture* - An elevated **CSF opening pressure** (normal range typically below 20-25 cmH₂O) is a common finding in bacterial meningitis, indicating **intracranial hypertension** due to inflammation and edema. - While it reflects the severity of the initial insult, it is not a direct factor that dictates the *length* of antibiotic treatment; instead, it guides supportive measures to reduce intracranial pressure. *CSF white cell count of 5,000 cells/mm³ at initial presentation* - A **CSF white cell count** of 5,000 cells/mm³ is extremely high and characteristic of severe bacterial meningitis, indicating a robust inflammatory response within the central nervous system. - Although it points to a severe infection, the *initial* CSF cell count alone does not determine the *total duration* of antibiotic therapy, which is primarily guided by the identified pathogen, its sensitivities, and the patient's clinical response. *Development of seizure activity on day 2 of admission* - **Seizures** are a relatively common acute complication of bacterial meningitis, often occurring early in the course due to cerebral inflammation, edema, or vasculitis. - While they signify neurological involvement and require **anticonvulsant management**, their occurrence early in the admission does not automatically necessitate an extension of the antibiotic course, unless they are linked to ongoing, uncontrolled infection or evolving focal complications. *Isolation of penicillin-resistant Streptococcus pneumoniae from CSF culture* - The isolation of **penicillin-resistant Streptococcus pneumoniae** requires modification of the initial empirical antibiotic regimen (e.g., adding **vancomycin** to a third-generation cephalosporin like **ceftriaxone**) to ensure effective coverage based on susceptibility. - However, once an effective and appropriate antibiotic regimen is established, the mere fact of initial resistance does not, by itself, require extending the *duration* of treatment beyond the standard recommended course (e.g., 10-14 days for pneumococcal meningitis), provided the patient demonstrates a good clinical response.

Question 28: A 4-year-old boy who recently emigrated from Pakistan presents with a 4-week history of lethargy, low-grade fever, and behavioural changes. His mother reports he has been increasingly drowsy over the past week. Examination reveals temperature 37.8°C, Glasgow Coma Scale 13/15, and subtle right-sided weakness. Lumbar puncture shows: opening pressure 24 cmH₂O, CSF protein 3.2 g/L, glucose 1.4 mmol/L (plasma glucose 5.6 mmol/L), white cells 280/mm³ (85% lymphocytes). CT head shows basal meningeal enhancement and hydrocephalus. Which one of the following is the most appropriate initial management?

A. Start rifampicin, isoniazid, pyrazinamide, ethambutol, and high-dose dexamethasone (Correct Answer)
B. Commence ceftriaxone, vancomycin, and aciclovir pending CSF culture results
C. Arrange urgent neurosurgical insertion of ventriculoperitoneal shunt before starting treatment
D. Start rifampicin, isoniazid, pyrazinamide, and ethambutol only, avoiding steroids due to immunosuppression risk
E. Perform CSF TB PCR and defer treatment until molecular confirmation obtained

Explanation: ***Start rifampicin, isoniazid, pyrazinamide, ethambutol, and high-dose dexamethasone***- The clinical presentation of subacute fever, **lymphocytic pleocytosis**, very high protein, very low glucose, and **basal meningeal enhancement** with **hydrocephalus** in a child from an endemic area is classic for **Tuberculous Meningitis (TBM)**.- Inclusion of **adjunctive corticosteroids** (dexamethasone) is mandatory as it significantly reduces **mortality** and neurological morbidity by decreasing intracranial inflammation.*Commence ceftriaxone, vancomycin, and aciclovir pending CSF culture results*- This regimen targets acute **bacterial and viral meningitis**, which typically present with a more rapid onset and **neutrophilic pleocytosis** (for bacterial).- It fails to address **Mycobacterium tuberculosis**, which is the primary suspicion given the **emigration history** and characteristic subacute course and CSF profile.*Arrange urgent neurosurgical insertion of ventriculoperitoneal shunt before starting treatment*- While **hydrocephalus** may eventually require surgical intervention, medical management of the underlying infection and inflammation must be initiated **immediately**.- Surgical shunting does not treat the primary cause of TBM and should not **delay** life-saving anti-tuberculous chemotherapy, which may itself reduce hydrocephalus.*Start rifampicin, isoniazid, pyrazinamide, and ethambutol only, avoiding steroids due to immunosuppression risk*- Avoiding steroids is incorrect in the context of TBM; they are a **grade A recommendation** to minimize **vasculitis**, cerebral edema, and subsequent neurological damage.- The benefits of reducing **intracranial pressure** and neurological deficits far outweigh the risks of temporary immunosuppression in this severe condition.*Perform CSF TB PCR and defer treatment until molecular confirmation obtained*- **Tuberculous meningitis** is a medical emergency; any delay in treatment is associated with rapid **neurological decline** and death.- While **PCR/GeneXpert** is helpful, sensitivity can be low, and treatment should be started based on **clinical suspicion** and CSF findings alone without waiting for confirmation.

Question 29: A 47-year-old man from Georgia is diagnosed with pulmonary tuberculosis. Molecular testing shows rifampicin resistance. He is started on an appropriate modified regimen. After 4 months of treatment, he reports orange discoloration of his contact lenses. Which one of the following medications in his current regimen is most likely responsible for this adverse effect?

A. Levofloxacin
B. Linezolid
C. Bedaquiline
D. Clofazimine (Correct Answer)
E. Cycloserine

Explanation: ***Clofazimine*** - **Clofazimine** is a core component of the modified regimen for **rifampicin-resistant tuberculosis** and is notorious for causing **orange-brown to reddish-black discoloration** of skin and body fluids. - This drug accumulates in tissues and is excreted in **tears**, which can lead to the permanent staining of **contact lenses** and other body secretions. *Levofloxacin* - This **fluoroquinolone** is commonly used in drug-resistant TB but is primarily associated with **tendonitis**, tendon rupture, and **QT prolongation**. - It does not cause pigmentary changes or discoloration of body fluids or medical devices. *Linezolid* - **Linezolid** is an oxazolidinone used for resistant TB, known for causing **myelosuppression** (anemia, thrombocytopenia) and **peripheral neuropathy**. - It may cause a reversible **black hairy tongue**, but it does not cause orange staining of contact lenses or tears. *Bedaquiline* - **Bedaquiline** inhibits mycobacterial ATP synthase and is a key drug for MDR-TB, but its main safety concerns are **hepatotoxicity** and **QTc interval prolongation**. - Unlike the riminophenazine dye derivatives, it does not possess pigment-staining properties that affect **contact lenses**. *Cycloserine* - This second-line agent is frequently associated with **neuropsychiatric adverse effects**, including seizures, psychosis, and **depression**. - It lacks any metabolic pathways or chemical properties that would result in the **discoloration** of body fluids or secretions.

Question 30: According to current UK public health guidelines, which one of the following scenarios requires notification of suspected meningococcal disease to the local Health Protection Team before laboratory confirmation?

A. A 45-year-old man with confirmed Neisseria meningitidis isolated from CSF
B. A 22-year-old woman with purpuric rash and suspected meningococcal septicaemia in the emergency department (Correct Answer)
C. A 35-year-old man with Neisseria meningitidis identified on blood culture after 48 hours
D. A 19-year-old student with viral meningitis confirmed by PCR testing
E. A 28-year-old woman with confirmed Streptococcus pneumoniae meningitis

Explanation: ***A 22-year-old woman with purpuric rash and suspected meningococcal septicaemia in the emergency department*** - Public health guidelines require **notification on clinical suspicion** of meningococcal disease to ensure rapid chemoprophylaxis for close contacts. - A **non-blanching purpuric rash** is a hallmark clinical sign that warrants immediate action before waiting for formal laboratory results. *A 45-year-old man with confirmed Neisseria meningitidis isolated from CSF* - While notification is required, the prompt asks which must be reported based on **suspicion before laboratory confirmation**. - Reporting at the point of **isolate identification** is too late for optimal public health intervention for high-risk contacts. *A 35-year-old man with Neisseria meningitidis identified on blood culture after 48 hours* - Notification should have occurred much earlier; waiting for **48-hour blood cultures** delays essential preventive measures for the community. - Statutory notification is mandated for **suspected cases**, not just laboratory-confirmed ones, to mitigate the risk of clusters. *A 19-year-old student with viral meningitis confirmed by PCR testing* - **Viral meningitis** is generally not a notifiable condition under standard UK public health regulations. - PCR confirmation of a virus does not trigger the same **emergency public health response** required for bacterial meningococcal disease. *A 28-year-old woman with confirmed Streptococcus pneumoniae meningitis* - **Streptococcus pneumoniae** causes serious illness but does not typically require immediate notification for contact tracing or prophylaxis. - Unlike *N. meningitidis*, it does not usually result in **outbreaks** requiring urgent intervention by the Health Protection Team.

Practice by Chapter

Meningitis

Practice Questions

Tuberculosis

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free